Cleared Special

K062431 - HEMOSIL LIQUID ANTITHROMBIN (FDA 510(k) Clearance)

Sep 2006
Decision
11d
Days
Class 2
Risk

K062431 is an FDA 510(k) clearance for the HEMOSIL LIQUID ANTITHROMBIN. This device is classified as a Antithrombin Iii Quantitation (Class II - Special Controls, product code JBQ).

Submitted by Instrumentation Laboratory CO (Bedford, US). The FDA issued a Cleared decision on September 1, 2006, 11 days after receiving the submission on August 21, 2006.

This device falls under the Hematology FDA review panel. Regulated under 21 CFR 864.7060.

Submission Details

510(k) Number K062431 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received August 21, 2006
Decision Date September 01, 2006
Days to Decision 11 days
Submission Type Special
Review Panel Hematology (HE)
Summary Summary PDF

Device Classification

Product Code JBQ — Antithrombin Iii Quantitation
Device Class Class II - Special Controls
CFR Regulation 21 CFR 864.7060